Evidence map›Paper›PMID 39916520›Full record

ArticleDiagnosis (Berlin, Germany)2025

Pioneering diagnosis in Asia: advancing clinical reasoning expertise through the lens of 3M.

Taro Shimizu, Satoshi Watanuki, Yukinori Harada, Ren Kawamura, Masayuki Amano, Sho Isoda, Kotaro Kunitomo, Mamoru Komatsu, Taiju Miyagami, Kosuke Ishizuka and 2 more

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in Diagnosis (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Taro ShimizuJapan Diagnostic Excellence Team, Japan.ORCID https://orcid.org/0000-0002-3788-487X
Satoshi WatanukiJapan Diagnostic Excellence Team, Japan.
Yukinori HaradaJapan Diagnostic Excellence Team, Japan.ORCID https://orcid.org/0000-0001-6042-7397
Ren KawamuraJapan Diagnostic Excellence Team, Japan.ORCID https://orcid.org/0000-0002-5632-3218
Masayuki AmanoJapan Diagnostic Excellence Team, Japan.ORCID https://orcid.org/0000-0001-6948-1840
Sho IsodaJapan Diagnostic Excellence Team, Japan.ORCID https://orcid.org/0000-0002-2163-4841
Kotaro KunitomoJapan Diagnostic Excellence Team, Japan.
Mamoru KomatsuJapan Diagnostic Excellence Team, Japan.
Taiju MiyagamiJapan Diagnostic Excellence Team, Japan.ORCID https://orcid.org/0000-0002-4893-2224
Kosuke IshizukaJapan Diagnostic Excellence Team, Japan.ORCID https://orcid.org/0000-0003-4313-6592
Shintaro KosakaJapan Diagnostic Excellence Team, Japan.
Masaru KuriharaJapan Diagnostic Excellence Team, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical reasoningdiagnostic errordiagnostic excellenceimproving diagnosis

Identifiers

PMID39916520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.